Evidence map›Paper›PMID 39456691›Full record

ArticleInternational journal of molecular sciences2024

Serpin Family B Member 2 Polymorphisms in Patients with Diabetic Kidney Disease: An Association Study.

Maria Tziastoudi, Georgios Pissas, Spyridon Golfinopoulos, Georgios Filippidis, Christina Poulianiti, Evangelia E Tsironi, Efthimios Dardiotis, Theodoros Eleftheriadis, Ioannis Stefanidis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Role ofGenes · 2026
    Pooled it
  2. IJMS Special Issue-Molecular Mechanisms of Diabetic Kidney Disease 2.0.International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria TziastoudiDepartment of Nephrology, School of Medicine, University of Thessaly, Panepistimiou 3, Biopolis, 41500 Larissa, Greece.ORCID 0000-0002-7206-2716
Georgios PissasDepartment of Nephrology, School of Medicine, University of Thessaly, Panepistimiou 3, Biopolis, 41500 Larissa, Greece.
Spyridon GolfinopoulosDepartment of Nephrology, School of Medicine, University of Thessaly, Panepistimiou 3, Biopolis, 41500 Larissa, Greece.
Georgios FilippidisDepartment of Nephrology, School of Medicine, University of Thessaly, Panepistimiou 3, Biopolis, 41500 Larissa, Greece.
Christina PoulianitiDepartment of Nephrology, School of Medicine, University of Thessaly, Panepistimiou 3, Biopolis, 41500 Larissa, Greece.
Evangelia E TsironiOphthalmology Clinic, University of Thessaly, 41335 Larissa, Greece.ORCID 0000-0002-6514-6559
Efthimios DardiotisNeurology, General University Hospital of Larissa, 41500 Larissa, Greece.ORCID 0000-0003-2957-641X
Theodoros EleftheriadisDepartment of Nephrology, School of Medicine, University of Thessaly, Panepistimiou 3, Biopolis, 41500 Larissa, Greece.ORCID 0000-0001-9302-1633
Ioannis StefanidisDepartment of Nephrology, School of Medicine, University of Thessaly, Panepistimiou 3, Biopolis, 41500 Larissa, Greece.ORCID 0000-0002-5515-8089

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic kidney disease (DKD) is a serious microvascular complication of type 2 diabetes mellitus (T2DM). Despite the numerous genetic loci that have been associated with the disease in T2DM, the genetic architecture of DKD remains unclear until today. In contrast to

Indexed as

Diabetes Mellitus, Type 2Diabetic NephropathiesGenetic Predisposition to DiseasePlasminogen Activator Inhibitor 2Polymorphism, Single NucleotideAgedCase-Control StudiesFemaleGenetic Association StudiesHumansIntracellular Signaling Peptides and ProteinsMaleMiddle AgedIntracellular Signaling Peptides and ProteinsPlasminogen Activator Inhibitor 2SERPINB2 protein, humanassociation studydiabetes mellitusdiabetic kidney diseasepolymorphismSerpin Family B Member 2 (SERPINB2)

Identifiers

PMID39456691
PMCPMC11508130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.